Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 1
2018 1
2020 4
2021 3
2022 4
2023 1
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Radiotherapy for HPV-related cancers: prediction of therapeutic effects based on the mechanism of tumor immunity and the application of immunoradiotherapy.
Someya M, Fukushima Y, Hasegawa T, Tsuchiya T, Kitagawa M, Gocho T, Mafune S, Ikeuchi Y, Kozuka Y, Hirohashi Y, Torigoe T, Iwasaki M, Matsuura M, Saito T, Sakata KI. Someya M, et al. Among authors: fukushima y. Jpn J Radiol. 2022 May;40(5):458-465. doi: 10.1007/s11604-021-01231-4. Epub 2022 Jan 1. Jpn J Radiol. 2022. PMID: 34973113 Free PMC article. Review.
Combined chemoradiotherapy and programmed cell death-ligand 1 blockade leads to changes in the circulating T-cell receptor repertoire of patients with non-small-cell lung cancer.
Someya M, Tokita S, Kanaseki T, Kitagawa M, Hasegawa T, Tsuchiya T, Fukushima Y, Gocho T, Kozuka Y, Mafune S, Ikeuchi Y, Takahashi M, Moniwa K, Matsuo K, Hasegawa T, Torigoe T, Sakata KI. Someya M, et al. Among authors: fukushima y. Cancer Sci. 2022 Dec;113(12):4394-4400. doi: 10.1111/cas.15566. Epub 2022 Sep 21. Cancer Sci. 2022. PMID: 36069051 Free PMC article.
Prediction of treatment response from the microenvironment of tumor immunity in cervical cancer patients treated with chemoradiotherapy.
Someya M, Tsuchiya T, Fukushima Y, Hasegawa T, Hori M, Kitagawa M, Gocho T, Mafune S, Ikeuchi Y, Hirohashi Y, Torigoe T, Iwasaki M, Matsuura M, Saito T, Matsumoto Y, Sakata KI. Someya M, et al. Among authors: fukushima y. Med Mol Morphol. 2021 Sep;54(3):245-252. doi: 10.1007/s00795-021-00290-w. Epub 2021 May 8. Med Mol Morphol. 2021. PMID: 33963949
Predictive value of an exosomal microRNA-based signature for tumor immunity in cervical cancer patients treated with chemoradiotherapy.
Someya M, Hasegawa T, Tsuchiya T, Kitagawa M, Fukushima Y, Gocho T, Mafune S, Ikeuchi Y, Kozuka Y, Idogawa M, Hirohashi Y, Torigoe T, Iwasaki M, Matsuura M, Saito T, Sakata KI. Someya M, et al. Among authors: fukushima y. Med Mol Morphol. 2023 Mar;56(1):38-45. doi: 10.1007/s00795-022-00338-5. Epub 2022 Nov 11. Med Mol Morphol. 2023. PMID: 36367588
Influence of XRCC4 expression in esophageal cancer cells on the response to radiotherapy.
Hori M, Someya M, Matsumoto Y, Nakata K, Kitagawa M, Hasegawa T, Tsuchiya T, Fukushima Y, Gocho T, Sato Y, Ohnuma H, Kato J, Sugita S, Hasegawa T, Sakata KI. Hori M, et al. Among authors: fukushima y. Med Mol Morphol. 2017 Mar;50(1):25-33. doi: 10.1007/s00795-016-0144-5. Epub 2016 Jun 23. Med Mol Morphol. 2017. PMID: 27338590
15 results